Kura Oncology (KURA) Receivables - Other (2014 - 2020)
Kura Oncology (KURA) posted quarterly Receivables - Other of $31000.0 for Q1 2020, down 82.68% year-over-year from $179000.0 in Q2 2019, and up 3.33% quarter-over-quarter from $30000.0 in Q4 2019.
Kura Oncology (KURA) Receivables - Other (2014 - 2020) Analysis & Trends
Kura Oncology (KURA) has reported Receivables - Other for 7 consecutive years, with $31000.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Receivables - Other fell 82.68% year-over-year to $31000.0; the TTM figure through Mar 2020 stood at $31000.0 (down 82.68% YoY), while the FY2019 annual figure was $30000.0, down 86.61% from the prior year.
- Receivables - Other climbed to $31000.0 in Q1 2020 per KURA's latest filing, from $30000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $406000.0 in Q1 2016 and bottomed at $30000.0 in Q4 2019.
- Historically, Receivables - Other has averaged $215235.3 across 5 years, with a median of $230000.0 in 2018.
- Annual changes were most pronounced in 2016 — Receivables - Other increased 16.33% — and 2019, when it plunged 86.61%.
- Kura Oncology's Receivables - Other stood at $295000.0 in 2016, then declined by 26.78% to $216000.0 in 2017, then advanced by 3.7% to $224000.0 in 2018, then slumped by 86.61% to $30000.0 in 2019, then advanced by 3.33% to $31000.0 in 2020.
- Business Quant data shows KURA's Receivables - Other at $31000.0 in Q1 2020, $30000.0 in Q4 2019, and $47000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 31,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 216,000.00 |
| Dec 31, 2017 | 216,000.00 |